Related Experiment Video
Updated: Jun 6, 2026

05:19
Automated Compression Testing of the Ocular Lens
Published on: April 5, 2024
Exploring oculomotor challenges in amyotrophic lateral sclerosis: a comprehensive review
Dongchao Shen1, Anfeng Liu2, Xunzhe Yang1
1Department of Neurology, Peking Union Medical College Hospital, Beijing, China.
Summary
Amyotrophic lateral sclerosis (ALS) affects more than motor neurons, impacting eye movements. Eye-tracking (ET) reveals these oculomotor deficits, correlating with cognitive decline and aiding ALS assessment.
Area of Science:
- Neuroscience
- Ophthalmology
- Neurology
Background:
- Amyotrophic lateral sclerosis (ALS) is increasingly recognized as a multisystem neurodegenerative disorder beyond its motor neuron origins.
- The oculomotor system is implicated in ALS, with dysfunction potentially reflecting broader disease processes.
Purpose of the Study:
- To review current evidence on oculomotor dysfunction in amyotrophic lateral sclerosis (ALS).
- To explore the relationship between eye-tracking (ET) metrics and motor/cognitive impairments in ALS.
- To highlight the utility of ET as a noninvasive tool for assessing ALS progression.
Main Methods:
- This study is a narrative review of existing literature.
- Key eye-tracking (ET) metrics examined include saccades, smooth pursuit, and fixation.
- Analysis focuses on the correlation between oculomotor function and disease-related impairments.
Main Results:
- Oculomotor impairments are evident in ALS patients and are more pronounced in those with bulbar-onset disease.
- Eye-tracking (ET) metrics can reflect both motor and extramotor neurodegeneration.
- Oculomotor dysfunction is linked to cognitive decline in ALS.
Conclusions:
- Eye-tracking (ET) offers a noninvasive method for assessing ALS progression and severity.
- Oculomotor metrics provide insights into the impact of ALS on multiple neural networks.
- These findings can inform refined patient assessment and care strategies, especially in advanced ALS stages.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
977
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
977
Accessory Structures of the Eye
1.3K
Optical perception, or vision, is an extraordinary sense dependent on converting light signals received via the ocular organs. These organs, known as eyes, are securely positioned within the bony cavities of the skull, called orbits. The orbits serve a dual purpose: a protective shield for the ocular globes and a stable attachment point for the soft ocular tissues. The eye's external protective mechanisms include the eyelids, which are edged with lashes that act as a barrier against foreign...
1.3K

